This evidence could explain the discrepancies about the role of NLRP3 or not in COPD onset, pointing the attention at the experimental conditions that could be pivotal for the identification of the inflammasome activation. This evidence concerns the gene NLRP3 and chronic obstructive pulmonary disease.